Last Updated on July 25, 2024 by The Health Master
Maharashtra FDA
The Maharashtra Food and Drug Administration (Maharashtra FDA) conducted a successful raid on July 10th, 2024, uncovering a major case of unlicensed Ayurvedic drug manufacturing.
The operation, spanning three locations in Vasai, District Palghar, targeted M/s Gaharwar Pharma Products Pvt. Ltd.
Unlicensed Manufacturing of Ayurvedic Drugs:
- The company held a license for Ayurvedic drug production in Haryana, but investigations revealed actual manufacturing happening at the Vasai facility without a proper license.
- Authorities suspect the Haryana license was surrendered in May 2024, yet production continued illegally at Vasai.
Dubious Distribution Network:
- The manufactured drugs were supposedly intended for sale to Onkar Pharma in Jalandhar, Punjab. However, this company also operated from Vasai, raising concerns about distribution practices.
- Additionally, some seized drugs displayed a manufacturing address of Gaharwar Pharma Pvt. Ltd., Navghar Vasai, with a production date of January 2024. This facility previously belonged to Rushabh Medicines, whose license was revoked in 2022.
Significant Seizure and Ongoing Investigation:
- The Maharashtra FDA confiscated Ayurvedic drugs, raw materials, machinery, packaging materials, labels, and pouches with an estimated value of ₹1.41 crore.
- This raid follows similar actions taken in March 2024 and 2021 against the company’s sister concern, Rushabh Medicines. Violations included allopathic drugs found in Ayurvedic medicines, leading to legal action and license cancellation.
Officials Involved in the Raid:
- The operation involved Drugs Inspectors Yogendra Pol, Nitin Aher, and Kailash Khapekar from Palghar and Thane, supported by Assistant Commissioners and Drug Inspectors from Thane, Palghar, and Greater Mumbai.
- Additional support came from VR Ravi, Assistant Commissioner (IB Mumbai), and Shashikant Yadav, Drugs Inspector (IB Mumbai).
Maharashtra FDA Commissioner Leads the Initiative:
- The raid was conducted under the guidance of Maharashtra FDA Commissioner Abhimanyu Kale, Dr. Rahul Khade (Joint Commissioner, FDA Vigilance), Narendra Supe (Joint Commissioner, FDA Thane), and Vijay Jadhav (Joint Commissioner, FDA Greater Mumbai).
The Takeaway:
This significant raid highlights the Maharashtra FDA’s commitment to ensuring public safety and adherence to regulations in the Ayurvedic drug manufacturing industry.
Further investigation is underway, with potential legal action against the manufacturer upon completion.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
FDA Maharashtra: Two Agencies Accused of Distributing Spurious Drugs
No More Discount Banners for Pharmacies in Maharashtra
FDA Maharashtra: Crackdown on Illicit Cosmetic Manufacturing
FDA Maharashtra: Action Against Illicit Drug Sales
Telangana DCA seizes illegally stocked and overpriced medicines
USFDA approval granted for this chronic heart failure treatment drug
PCI frames new Regulations in accordance with Jan Vishwas Act
USFDA declines to approve this weekly Insulin
Excipients: Need to enforce stringent Regulatory Standards for quality
Indian Regulators Cracks Down with Mandatory Barcodes on Top Brands
USFDA approval granted for generic Bromfenac Ophthalmic Solution
NPPA Seeks Clarity on Regulatory Requirements for this Inhaler Device
Inspections to be started for compliance of Revised Schedule M: Tamil Nadu
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
